A pilot safety, feasibility and efficacy study of an oral anticoagulant, apixaban, in secondary prophylaxis of a primary venous thromboembolism in children and adolescents.

Ashley PinchinatOya Levendoglu-TugalYara PerezEmily ThatcherNeida OteroArvind BudhramHarshini MahantiErin MorrisLiana KlejmontEdo SchaeferAdele BrudnickiDeborah FriedmanSimon LiMitchell S Cairo

Published in: British journal of haematology (2023)

Keyphrases

venous thromboembolism
direct oral anticoagulants
atrial fibrillation
randomized controlled trial
study protocol
double blind